View Post

Lower dose of oestrogen receptor modulator seems to reduce risk of breast cancer

In Clinical Studies News by Barbara Jacoby

Source: Karolinska Institutet From: While the drug tamoxifen reduces the risk of developing breast cancer and prevents recurrence, the side-effects cause many women to discontinue their treatment. A study involving researchers at Karolinska Institutet in Stockholm has now found that a much lower dose than the standard produces a good effect with fewer adverse reactions in women who have …

View Post

A group of cancer doctors discovered a way to slash the cost of expensive pills by up to 75%, but they’ve hit a wall

In In The News by Barbara Jacoby

By: Lydia Ramsey From: The cost of certain cancer drugs has gotten high, often to more than $100,000 a year. To combat that, researchers are looking for treatments that could be taken at a lower dose, so long as they’re taken with food. But finding the funding to study lower doses hasn’t been easy. Dr. Mark Ratain, the chief …